Xencor to Host First Quarter 2021 Financial Results Webcast and Conference Call on May 5, 2021

Rhea-AI Summary

Xencor, Inc. (NASDAQ: XNCR) announced its plans to release first quarter 2021 financial results after market close on May 5, 2021. A conference call will be held the same day at 4:30 p.m. ET to discuss the results and provide a corporate update. Interested parties can access the call by dialing (877) 359-9508 or through an online webcast available on Xencor's website. The company is focused on developing engineered monoclonal antibodies and cytokines for cancer and autoimmune disease treatments, with 21 candidates in clinical development.

Positive

• 21 candidates in clinical development enhance business prospects.

Negative

• None.

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that it will release first quarter 2021 financial results after the market closes on Wednesday, May 5, 2021.

Xencor management will host a webcast and conference call the same day at 4:30 p.m. ET (1:30 p.m. PT) to discuss the financial results and provide a corporate update.

The live call may be accessed by dialing (877) 359-9508 for domestic callers or (224) 357-2393 for international callers and referencing conference ID number 2378094. A live webcast of the conference call will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. The webcast will be archived on the company website for 30 days.

About Xencor, Inc.

Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases. Currently, 21 candidates engineered with Xencor's XmAb^® technology are in clinical development internally and with partners. Xencor's XmAb antibody engineering technology enables small changes to the structure of proteins resulting in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210428006025/en/

FAQ

When will Xencor release its first quarter 2021 financial results?

Xencor will release its first quarter 2021 financial results after market close on May 5, 2021.

What time is the Xencor conference call scheduled?

The conference call is scheduled for May 5, 2021, at 4:30 p.m. ET.

How can I access Xencor's conference call?

You can access the conference call by dialing (877) 359-9508 for domestic callers or (224) 357-2393 for international callers, referencing conference ID number 2378094.

Where can I find the webcast of the Xencor conference call?

The webcast of the conference call will be available under 'Events & Presentations' in the Investors section of Xencor's website.

What is the focus of Xencor's drug development?

Xencor focuses on developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases.